MRD / Regn No. : THBC\23-24\02749 Date : 22/07/2026
Patient Name : Nirupama Shah Age & Gender : 71 Yrs. / Female
Contact No. : 9820766966 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (13/Jun/2000) | HTN (13/Jul/2011) |
Subjective : T2DM/HTN,PTCA-NOV 23,PACEMAKER IN SITU,HYPOS RESOLVED,BETTER PROTEIN INTAKE,LAST HBA1C-8.7%,NO ISSUE WITH MEDS,NOT INCREASING DOSE OF DIAMICRON AT NIGHT AS HAS LOW SUGARS
Objective : 02-JUL-2026 REPORTS,HB-12.6,CR-1.03,ALT-16.22/ AST-25.54,T3-1.21/ T4-8.02/ TSH-4.76,TC-157.90/ TG-153.71/ LDL-72.25/ HDL-54.91,FBS-110.97,HBA1C-9.88%,VITD-43.39,VITB12-> 2000
Analysis : ANGIZEM CD 90 / CLOPIVAS AP
Plan : ACCEPTING HBA1C 8% AS LOWER HBA1C INCREASES RISK OF HYPOGLYCEMIA  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET GLICLAZIDE XR 60 MG
DIAMICRON XR 60 MG
ORAL 1-0-1/2 BBF / BD
6 MTHS
2 EUREPA V 1+0.2 MG ORAL 1-1-1 BBF / BL / BD
6 MTHS
3 ZOMELIS DM 10/100/1000 MG ORAL 1-0-0 ABF
6 MTHS
4 UPRISE 60,000 UNITS ORAL ONCE A WEEK ANYTIME OF DAY
6 MTHS
5 TELMA 40 MG ORAL 1-0-0 ABF
6 MTHS
6 ROSUVAS 20 ORAL 0-0-1 AD
6 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 04/Mar/2026
Tests Suggested For Next Visit : HBA1C > 3 MTHS - TEXT ME - IF CLOSE TO 8% OR LESS - VISIT NOT NEEDED,AFTER 6 MTHS - HBA1C / FBS / PPBS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: